Treating Comorbid Insomnia with Obstructive Sleep Apnoea (COMISA): A randomised controlled trial evaluating the effectiveness of a new treatment strategy incorporating Cognitive Behaviour Therapy for Insomnia (CBTi) plus treatment as usual for patients with combined insomnia and sleep apnoea

Prof Doug McEvoy0 个研究点目标入组 140 人开始时间: 2013年10月28日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1. Age greater than or equal to18 years of age up to and including 75 years of age. 2. An apnoea/hypopnoea index (AHI) greater than 15 events per hour of sleep by polysomnography (PSG) with clinical diagnosis of OSA confirmed by treating consultant respiratory physician. 3. Recommended by treating sleep physician for CPAP treatment. 4. A diagnosis of Insomnia to ICSD-2 criteria, Insomnia Severity Index Score greater than 13.

•1. Severe daytime sleepiness, or other reason, which in the opinion of the treating physician would cause undue risk to the patient’s safety during the CBTi treatment period while awaiting CPAP treatment.
•2. Any other sleep disorder (eg REM behaviour disorder, severe restless legs syndrome) which in the opinion of the treating physician is the dominant sleep diagnosis and which requires immediate treatment. Patients with other medical or psychiatric conditions (e.g. depression & anxiety) will not be excluded, but diagnoses recorded from the patient’s file for reporting and analysis purposes.

发起方

Prof Doug McEvoy